SciVida Welcomes New Boston Partner

BOSTON, June 18, 2025 – SciVida is pleased to announce Jonathan Hodgson has joined SciVida as a Partner in the firm’s Boston office.

Jonathan is a proven leader in life sciences consulting, bringing a wealth of experience from working with clients across a variety of pharmaceutical, biotechnology, and digital therapeutics companies for more than two decades and skillfully helping them navigate complex dynamics in rapidly changing markets. He is an expert in market access and commercial strategy and has particular capabilities in rare disease drug pricing, digital therapeutics, and oncology.

Jonathan has co-authored articles published in peer-reviewed and industry publications, including Journal of Clinical Pathways, PharmaVOICE, and In Vivo. He has also been a speaker at conferences such as DTx West, DTx East, and the European Pricing Forum.

Jonathan began his business career in consulting before pursuing his MBA. After completing his degree, he moved into life sciences at a leading biopharmaceutical company where he managed activities across business development and corporate strategy. He then pivoted back to consulting and over the past 20 years has built trusted advisor relationships with clients at life science organizations of all sizes. Jonathan also has a knack for cultivating cohesive teams and helping consultants develop professionally, talents that come at a pivotal time in the evolution of the firm’s Boston office.

Jonathan earned bachelor of arts degrees in both economics and geology from Dartmouth College and his MBA from Harvard Business School.